News Buzz: MOL Global, Inc. (NASDAQ:MOLG), Baxter International Inc. (NYSE:BAX), Reed Elsevier PLC (NYSE:RUK), Veeco Instruments Inc. (NASDAQ:VECO), ERBA Diagnostics, Inc. (NYSEMKT:ERB)

MOL Global, Inc. (NASDAQ:MOLG) belongs to Services sector. Its net profit margin is -1.20% and weekly performance is -8.41%. On last trading day company shares ended up $1.96. MOL Global, Inc. (NASDAQ:MOLG) distance from 50-day simple moving average (SMA50) is -13.01%. MOL Global, Inc. (NASDAQ:MOLG) reported Gross profit remained stable at MYR26.2 million (US$7.1 million) for the first quarter in 2014 and 2015 despite a 53.3% decline in MMOG.asia segment gross profit. Other than MMOG.asia, there was an increase in gross profit across all other segments. Gross profit margin was 45.7% in the first quarter of 2015, compared to 56.5% in the prior year period.

Baxter International Inc. (NYSE:BAX) shares moved down -0.27% in last trading session and ended the day at $67.04. BAX Gross Margin is 49.00% and its return on assets is 11.50%. Baxter International Inc. (NYSE:BAX) quarterly performance is -1.89%. Baxter International Inc. (NYSE:BAX) will begin trading ex-dividend on May 28, 2015. A cash dividend payment of $0.52 per share is scheduled to be paid on July 01, 2015.

On 27 May, Reed Elsevier PLC (NYSE:RUK) shares advanced 0.42% and was closed at $67.61. RUK EPS growth in last 5 year was 19.20%. Reed Elsevier PLC (NYSE:RUK) year to date (YTD) performance is 1.12%. Zacks lowered shares of Reed Elsevier plc (NYSE:RUK) from a hold rating to a sell rating in a report released on Tuesday.

Veeco Instruments Inc. (NASDAQ:VECO) ended the last trading day at $30.47. Company weekly volatility is calculated as 3.67% and price to cash ratio as 3.14. Veeco Instruments Inc. (NASDAQ:VECO) showed a weekly performance of -2.15%. Veeco Instruments Inc. (NASDAQ:VECO) announced that on Wednesday, June 3, 2015 at the Bank of America Merrill Lynch Global Technology Conference at the Ritz-Carlton Hotel in San Francisco, CA.

ERBA Diagnostics, Inc. (NYSEMKT:ERB) shares moved down -1.44% in last trading session and ended the day at $2.73. ERB Gross Margin is 47.70% and its return on assets is 2.30%. ERBA Diagnostics, Inc. (NYSEMKT:ERB) quarterly performance is -20.41%. On 18 May, ERBA Diagnostics, Inc. (NYSE MKT:ERB), reported its financial results for the year ended December 31, 2014. Net income for the year ended December 31, 2014 was $450,000, compared to net income of $676,000 for the year ended December 31, 2013. Net revenues for the year ended December 31, 2014 were $26,392,000, compared to net revenues of $28,255,000 for the year ended December 31, 2013.

Leave a Reply

Your email address will not be published. Required fields are marked *